Inactive Instrument

Calendar Theravance Inc Nasdaq

Equities

US88338T1043

End-of-day quote Nasdaq Other stock markets
- ^USD	-

24/04	Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024	CI
04/03	Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit	MT

Chart calendar Theravance Inc

81be29175012bdc8e38d2dae7.WPwfPgnpIT-BRRHKwT0klkAaBdSXdeLszZuSPWYiOMQ.Yc5UbDCPFQfEc2SzrFMWzxZOX63lMJOpgtXQSyloDP0WulF6SplLcsovWA~0735a83314de16144edcad7b9241c064

Upcoming events on Theravance Inc

24/07/2024	Q2 2024 Earnings Release (Projected)
30/10/2024	Q3 2024 Earnings Release (Projected)
05/02/2025	Q4 2024 Earnings Release (Projected)

Past events on Theravance Inc

01/05/2024	Q1 2024 Earnings Release (Projected)
30/04/2024 12:00 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 246
29/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 1421
29/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 1281
29/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 1816
28/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 2527
28/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 2424
28/04/2024 03:30 pm	European Society of Clinical Microbiology and Infectious Disease Global Congress - Poster No - 2724
01/03/2024 02:35 am	Q4 2023 Earnings Release
02/11/2023 01:45 am	Q3 2023 Earnings Release
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2517
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2515
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2526
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2121
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2133
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2132
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2138
14/10/2023 09:45 pm	IDWeek Conference - Poster No:2549
12/10/2023 08:00 pm	IDWeek Conference
27/09/2023 11:20 pm	Cantor Global Healthcare Conference

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	261 257 1.38%	337 261 29.25%	392 292 34.12%	331 338 -1.83%	310 300 3.44%	301
EBITDA Million USD	Released Forecast Spread	260 255 2.13%	335 246 36.13%	389 274 42.09%	221 229 -3.42%	0,00 144 -	115
EBIT Million USD	Released Forecast Spread	246 242 1.9%	321 245 31.1%	375 273 37.64%	207 218 -5.11%	136 116 17.25%	95,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	233 229 1.7%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
Net income Million USD	Released Forecast Spread	157 156 0.83%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EPS USD	Released Forecast Spread	1,43 1,38 3.62%	0,00 0,00 -	0,00 0,00 -	2,37 0,85 178.82%	0,00 0,00 -	0,00
Announcement Date		05/02/20	03/02/21	09/02/22	28/02/23	29/02/24	-

Quarterly results

Fiscal Period	December	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	90,1 86,4 4.23%	108 215 -49.61%	67,3 200 -66.45%	65,8 58,9 11.81%	76,4 62,0 23.16%	81,0 67,9 19.25%	67,3 75,7 -11.1%	85,8 75,5 13.67%	68,0	75,8	73,1	83,8
EBITDA Million USD	Released Forecast Spread		86,1 47,5 81.36%	27,9 37,8 -26.07%	25,6 39,7 -35.5%	38,8 35,9 8.01%
EBIT Million USD	Released Forecast Spread		82,6 325 -74.61%	22,5 173 -87.01%	24,2 21,0 14.96%	29,9 23,9 25.12%	33,5 22,8 46.61%	17,9 24,7 -27.44%	44,0 24,1 82.93%	20,6	25,6	19,3	30,2
Earnings before Tax (EBT) Million USD	Released Forecast Spread			286 34,9 720.7%		41,1 23,3 76.57%
Net income Million USD	Released Forecast Spread			266 27,0 883.42%		34,9 19,4 79.72%
EPS USD	Released Forecast Spread			2,80 0,31 803.23%	-0,98 0,29 -437.93%	0,42 0,23 82.61%
Announcement Date		27/04/22	27/07/22	09/11/22	28/02/23	09/05/23	02/08/23	01/11/23	29/02/24	-	-	-	-

Upcoming sector events for Theravance Inc

07/05/2024	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release (Projected)
07/05/2024	EVOLUS, INC.: Q1 2024 Earnings Release
07/05/2024	DR. REDDY'S LABORATORIES LIMITED: Q4 2024 Earnings Release
07/05/2024	PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release
07/05/2024	BLAU FARMACÊUTICA S.A.: Q1 2024 Earnings Release
07/05/2024 04:00 pm	PERRIGO COMPANY PLC: Q1 2024 Earnings Release
08/05/2024 01:30 am	OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release
08/05/2024 01:31 am	LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
08/05/2024 01:35 am	SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release
08/05/2024	IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected)

More events

Past sector events for Theravance Inc

Today	GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected)
Today	PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today	LUPIN LIMITED: Q4 2024 Earnings Release
Today	DRI HEALTHCARE TRUST: Q1 2024 Earnings Release
03/05/2024 04:37 pm	AARTI DRUGS LIMITED: Q4 2024 Earnings Release
03/05/2024 03:30 pm	AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
03/05/2024	SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected)
03/05/2024	DEVA HOLDING: Q1 2024 Earnings Release (Projected)
03/05/2024 01:31 am	AMGEN INC.: Q1 2024 Earnings Release
02/05/2024 11:13 pm	ALK-ABELLÓ A/S: Q1 2024 Earnings Release